Better-than-expected earnings from UnitedHealth Group ( UNH - Free Report ) and mixed results from Johnson & Johnson ( JNJ - Free Report ) also provided some support. UnitedHealth breezed past the Zacks Consensus Estimate on both earnings and revenues and lifted the full-year earnings outlook. Meanwhile, the world's biggest healthcare products' maker continued its long streak of earnings beat but lagged the revenue estimates. The company lifted its full-year guidance (read: JNJ Posts Mixed Q3 Bag, Ups View: ETFs in Focus ). Eli Lilly ( LLY - Free Report ) missed the Zacks Consensus Estimate but outpaced on the revenue front. It also raised its earnings outlook for the full year.